Gene-Based Therapeutics for Parkinson’s Disease

<div><p>Parkinson’s disease (PD) is a complex multifactorial disorder that is not yet fully surmised, and it is only when such a disease is tackled on multiple levels simultaneously that we should expect to see fruitful results. Gene therapy is a modern medical practice that theoreticall...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Karim E. Shalaby (12267224) (author)
مؤلفون آخرون: Omar M. A. El-Agnaf (8809331) (author)
منشور في: 2022
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513519178743808
author Karim E. Shalaby (12267224)
author2 Omar M. A. El-Agnaf (8809331)
author2_role author
author_facet Karim E. Shalaby (12267224)
Omar M. A. El-Agnaf (8809331)
author_role author
dc.creator.none.fl_str_mv Karim E. Shalaby (12267224)
Omar M. A. El-Agnaf (8809331)
dc.date.none.fl_str_mv 2022-07-26T03:00:00Z
dc.identifier.none.fl_str_mv 10.3390/biomedicines10081790
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Gene-Based_Therapeutics_for_Parkinson_s_Disease/25611642
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biological sciences
Biochemistry and cell biology
Genetics
neurodegeneration
Parkinson’s disease
gene therapy
dc.title.none.fl_str_mv Gene-Based Therapeutics for Parkinson’s Disease
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <div><p>Parkinson’s disease (PD) is a complex multifactorial disorder that is not yet fully surmised, and it is only when such a disease is tackled on multiple levels simultaneously that we should expect to see fruitful results. Gene therapy is a modern medical practice that theoretically and, so far, practically, has demonstrated its capability in joining the battle against PD and other complex disorders on most if not all fronts. This review discusses how gene therapy can efficiently replace current forms of therapy such as drugs, personalized medicine or invasive surgery. Furthermore, we discuss the importance of enhancing delivery techniques to increase the level of transduction and control of gene expression or tissue specificity. Importantly, the results of current trials establish the safety, efficacy and applicability of gene therapy for PD. Gene therapy’s variety of potential in interfering with PD’s pathology by improving basal ganglial circuitry, enhancing dopamine synthesis, delivering neuroprotection or preventing neurodegeneration may one day achieve symptomatic benefit, disease modification and eradication.</p><p> </p></div><h2>Other Information</h2> <p> Published in: Biomedicines<br> License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/biomedicines10081790" target="_blank">https://dx.doi.org/10.3390/biomedicines10081790</a></p>
eu_rights_str_mv openAccess
id Manara2_bb8d7946ff7766d493ef274e80efb37e
identifier_str_mv 10.3390/biomedicines10081790
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25611642
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Gene-Based Therapeutics for Parkinson’s DiseaseKarim E. Shalaby (12267224)Omar M. A. El-Agnaf (8809331)Biological sciencesBiochemistry and cell biologyGeneticsneurodegenerationParkinson’s diseasegene therapy<div><p>Parkinson’s disease (PD) is a complex multifactorial disorder that is not yet fully surmised, and it is only when such a disease is tackled on multiple levels simultaneously that we should expect to see fruitful results. Gene therapy is a modern medical practice that theoretically and, so far, practically, has demonstrated its capability in joining the battle against PD and other complex disorders on most if not all fronts. This review discusses how gene therapy can efficiently replace current forms of therapy such as drugs, personalized medicine or invasive surgery. Furthermore, we discuss the importance of enhancing delivery techniques to increase the level of transduction and control of gene expression or tissue specificity. Importantly, the results of current trials establish the safety, efficacy and applicability of gene therapy for PD. Gene therapy’s variety of potential in interfering with PD’s pathology by improving basal ganglial circuitry, enhancing dopamine synthesis, delivering neuroprotection or preventing neurodegeneration may one day achieve symptomatic benefit, disease modification and eradication.</p><p> </p></div><h2>Other Information</h2> <p> Published in: Biomedicines<br> License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/biomedicines10081790" target="_blank">https://dx.doi.org/10.3390/biomedicines10081790</a></p>2022-07-26T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/biomedicines10081790https://figshare.com/articles/journal_contribution/Gene-Based_Therapeutics_for_Parkinson_s_Disease/25611642CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/256116422022-07-26T03:00:00Z
spellingShingle Gene-Based Therapeutics for Parkinson’s Disease
Karim E. Shalaby (12267224)
Biological sciences
Biochemistry and cell biology
Genetics
neurodegeneration
Parkinson’s disease
gene therapy
status_str publishedVersion
title Gene-Based Therapeutics for Parkinson’s Disease
title_full Gene-Based Therapeutics for Parkinson’s Disease
title_fullStr Gene-Based Therapeutics for Parkinson’s Disease
title_full_unstemmed Gene-Based Therapeutics for Parkinson’s Disease
title_short Gene-Based Therapeutics for Parkinson’s Disease
title_sort Gene-Based Therapeutics for Parkinson’s Disease
topic Biological sciences
Biochemistry and cell biology
Genetics
neurodegeneration
Parkinson’s disease
gene therapy